| [1] PubMed ID: | 35359342 |
| Disease Name: | Carcinoma, Hepatocellular |
| Sample: | HCC samples |
| Dysfunction Pattern: | Interaction(miR-138-5p) |
| Validated Method: | Western Blot//Transfection//qPCR//IF//MTT//PCR//Transwell Assay |
| Description: | We observed that circ-TLK1 was highly expressed in HCC samples, and its high expression was closely associated with poor clinicopathological variables of HCC patients. The results of functional experiments revealed that knockdown of circ-TLK1 remarkably inhibited the proliferation, migration, invasion, and EMT of HCC cells, while circ-TLK1 overexpression promoted these malignant behaviors. Moreover, we noted that circ-TLK1 was capable of binding to miR-138-5p and upregulating its target gene, SOX4 in HCC. Based on rescue assays, miR-138-5p inhibition partially suppressed the effects of circ-TLK1 knockdown on the malignant behaviors of HCC cells. |
| Causality: | Yes |
| Causal Description: | The results of functional experiments revealed that knockdown of circ-TLK1 remarkably inhibited the proliferation, migration, invasion, and EMT of HCC cells, while circ-TLK1 overexpression promoted these malignant behaviors. |
| Clinical-realted Application: | We observed that circ-TLK1 was highly expressed in HCC samples, and its high expression was closely associated with poor clinicopathological variables of HCC patients. |
|